about
Down-regulation of CD81 in human cells producing HCV-E1/E2 retroVLPsImpact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.Small synthetic ligands for the enrichment of viral particles pseudotyped with amphotropic murine leukemia virus envelope.Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.Tryptophan tags and de novo designed complementary affinity ligands for the expression and purification of recombinant proteins.Metabolic flux profiling of MDCK cells during growth and canine adenovirus vector productionPalmitoylation Strengthens Cholesterol-dependent Multimerization and Fusion Activity of Human Cytomegalovirus Glycoprotein B (gB).Production of retroviral vectors: review.Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells.Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.Increased titer and reduced lactate accumulation in recombinant retrovirus production through the down-regulation of HIF1 and PDK.Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells.Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells.Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors.Insect cell line development using FLP-mediated cassette exchange technology.Bioprocess development for canine adenovirus type 2 vectors.Flipase-mediated cassette exchange in Sf9 insect cells for stable gene expression.Carboxylesterase 2 production and characterization in human cells: new insights into enzyme oligomerization and activity.Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.Down-regulation of CD81 tetraspanin in human cells producing retroviral-based particles: tailoring vector composition.Manufacturing of retroviruses.Integrated strategy for the production of therapeutic retroviral vectors.Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines.Retroviral vector production under serum deprivation: The role of lipids.Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer.Improving retroviral vectors production: role of carbon sources in lipid biosynthesis.Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.Relationship between retroviral vector membrane and vector stability.Retrovirus producer cell line metabolism: implications on viral productivity.The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability.Effect of medium sugar source on the production of retroviral vectors for gene therapy.Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity.Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation.Human carboxylesterase 2: Studies on the role of glycosylation for enzymatic activity.Insect cell culture medium supplementation with fetal bovine serum and bovine serum albumin: effects on baculovirus adsorption and infection kinetics.Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization.
P50
Q34175410-9248B9B6-D83F-488D-B30A-BDDA4548AFE6Q34658351-4CE15D77-18BF-42BD-A8BD-6352CC53A280Q35931803-17F271E8-4443-4BC4-B8BE-24724C9D383DQ36095367-6E8DFDCC-84BA-40AE-AC09-9D7D30DB1DA3Q36172528-1471CF2E-711E-4865-9B7E-50F0A83495B5Q36719271-0F95DE08-D7A0-4098-AEB3-1614BB8785D6Q36744572-6FAD7CB9-7D2A-4E74-9186-8C47872A0D88Q37807437-F3823E10-C381-457E-8402-B6569D8E664BQ38275653-72BC4694-E8CC-4423-A7B1-1E20CBF57E37Q38554795-1FB335C1-DF0C-480B-9FCD-58F00A498F6EQ38711978-3DDA91BF-04CB-4C60-8037-12448D8A8A49Q38857837-9DECF011-DA85-4C45-B077-9818C9703F80Q38872811-567F0D17-0966-403A-87E4-DE93C0325F14Q38879455-352F77ED-3377-45D7-A4B2-3083CAE4CF63Q38945731-83C82CF2-88A6-47E5-8719-AB4C2546572EQ39050962-7929F808-D2D9-4424-A3AA-49E98312EB80Q39319692-F4CBE195-1059-4167-810B-8C9069C1B9E0Q39352224-0BDD387E-9E94-40CA-9B61-4C7604056F63Q39374343-7814B51E-8D2F-4D5D-AB45-14E0701ABB99Q39425985-ABEA439C-C0F2-418B-B072-2ED85DCF264DQ39527949-B421E3B5-286C-4CED-A0A6-8BCA7E9CDBB9Q39540698-01D7EA75-7895-48E0-8447-A5D4D37F8742Q39636811-7630D0DF-60BD-4E6B-AB94-CB5D68B4C143Q39728912-7036A7D4-ED82-4F1B-A64E-A3AFF9E7C09CQ39816695-B15459DB-56E3-45BD-807C-0F7AE05716E3Q39841038-971E46DB-034D-43CD-B12A-E5EAFB8727EEQ39939692-7FC9AA2F-7942-4349-93FA-D45799DD31FAQ40033275-8AEBD3AE-27C6-4F0F-BD0F-81681D0543ADQ40280521-2ADA06C2-2FCB-4AE0-A51A-C78FB2673D56Q40294326-EC22FA17-E682-4FC9-8DCA-855750814599Q40295162-B306435A-BCB7-46C3-8521-740D8C048FEEQ40306462-63C3F1C7-26C7-43D8-BCE8-B0A0C9648BA0Q40306542-707AA39D-5AED-4BE5-8B66-9E03D903027CQ40309177-F2B36FEB-631B-491C-8E60-26F28D230D7FQ40960044-7BAB3BB6-D1F5-4A09-980C-B8379DB45B59Q41429339-E5CA25F8-5D3E-48A2-A1BA-1B1149BB0DDCQ41683457-72BDC8A0-1905-4FA9-8BFA-670206396498Q42050779-E123E922-DE42-4845-BB52-2B749DC076D4Q42262872-ED4BE037-C6E0-4D36-8C41-DE5BA6EEDAD0Q42408063-38621037-2DD0-449D-AAC6-5937A53055F1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana S Coroadinha
@es
Ana S Coroadinha
@nl
Ana S Coroadinha
@sl
Ana S. Coroadinha
@en
type
label
Ana S Coroadinha
@es
Ana S Coroadinha
@nl
Ana S Coroadinha
@sl
Ana S. Coroadinha
@en
prefLabel
Ana S Coroadinha
@es
Ana S Coroadinha
@nl
Ana S Coroadinha
@sl
Ana S. Coroadinha
@en
P106
P1153
6506989285
P21
P31
P496
0000-0001-9728-6890